no statement of use filed
on 07 Aug 2023
Last Applicant/ Owned by
1500 Main Street, Suite 2700
Springfield
MA
01115
Serial Number
88797477 filed on 14th Feb 2020
Registration Number
N/A
Correspondent Address
Katrin Lewertoff
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Consultancy in the field of biotechnology; Research and development in the field of biotechnology; Research and development in the field of immunology; Research and development in the field of biochemistry Biotechnological products, namely, chemicals for use in biotechnological product development for scientific purposes; Biological material, namely, biochemical preparations for scientific purposRead More
Consultancy in the field of biotechnology; Research and development in the field of biotechnology; Research and development in the field of immunology; Research and development in the field of biochemistry
Biotechnological products, namely, bio-chips for scientific purposes
Biotechnological products, namely, diagnostic reagents, medicines for gene therapy for the treatment of genetic diseases and/or cancer for medical purposes; Medicines for treating genetic disorders; Nanoparticles carrying drugs and nucleic acids for treating cancers; Synthetic peptide based nanoparticles for gene therapy for the treatment of genetic diseases and/or cancer; protein-based nanoparticles for gene therapy for the treatment of genetic diseases and/or cancer; cell-based therapeutic products, namely, vaccines; Pharmaceutical compounds for gene therapy for the treatment of genetic diseases and/or cancer; Biological material, namely, biological diagnostic preparations for gene therapy for the treatment of genetic diseases and/or cancer; Nucleic acids for medical purposes; proteins arrays for medical diagnosis purposes; cells for medical use; self-replicating nucleic acids for medical purposes; peptides for gene therapy for the treatment of genetic diseases and/or cancer; Eukaryotic cells for medical purposes; Prokaryotic cells for medical purposes; Stem cells for medical purposes; Living cells for medical purposes; Pharmaceutical compounds for gene therapy for the treatment of genetic diseases and/or cancer, vaccines, diagnostic rubbing compounds for medical purposes; Delivery vehicles, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Reagents for medical purposes; Diagnostic reagents for medicinal use; Bacteria for medical purposes; Diagnostic bacteria for medicinal use; Biochemical compounds for gene therapy for the treatment of genetic diseases and/or cancer for medical and veterinary application; Vaccines for medical and veterinary use
Biotechnological products, namely, chemicals for use in biotechnological product development for scientific purposes; Biological material, namely, biochemical preparations for scientific purposes; Cells for scientific purposes; Eukaryotic cells for scientific purposes; Prokaryotic cells for scientific purposes; Stem cells for scientific purposes; Living cells for scientific purposes; Reagents for scientific purposes; Diagnostic reagents for scientific use; Bacteria for scientific purposes; Diagnostic biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for scientific purposes; Nucleic acid for laboratory use; Proteins for use in manufacture; Small molecules being chemical compounds for use in patterning at nano scale or near nano scale
No 88797477
No Service Mark
No IPRK045UST
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 07th Aug 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 07th Aug 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 08th Dec 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 06th Dec 2022 | TEAS EXTENSION RECEIVED |
| 06th Dec 2022 | SOU EXTENSION 3 FILED |
| 06th Dec 2022 | SOU EXTENSION 3 GRANTED |
| 28th Jun 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 24th Jun 2022 | TEAS EXTENSION RECEIVED |
| 24th Jun 2022 | SOU EXTENSION 2 FILED |
| 24th Jun 2022 | SOU EXTENSION 2 GRANTED |
